Cybin Inc. Common Stock
HELP
Rank in Stocks
#11656
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Share Price
$10.30
Last synced: 2026-08-11
Market Cap
$638.32M
Change (1 day)
2.88%
Change (1 year)
9,119.52%
Country
CA
Trade Cybin Inc. Common Stock (HELP)
Category
Healthcare
Stock split history for Cybin Inc. Common Stock (HELP)
Cybin Inc. Common Stock stock (symbol: HELP) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One HELP share bought prior to Oct 20, 2026 would equal to 0 HELP shares today.
The most recent stock split occurred on Oct 20, 2026.
One HELP share bought prior to Oct 20, 2026 would equal to 0 HELP shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
